[{"data":1,"prerenderedAt":122},["ShallowReactive",2],{"drug-empagliflozin":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":44,"contraindications":84,"warnings":104,"renal":105,"monitoring":106,"interactions":107,"review":108,"examples":111},"empagliflozin",1,{"fa":7,"en":8},"امپاگلیفلوزین","Empagliflozin","endocrine",{"fa":11,"en":12},"مهارکننده SGLT2","SGLT2 inhibitor",[14],{"name":15,"market":16},"Jardiance","US",[18,19,7,20],"jardiance","جاردیانس","SGLT2",[22,36],{"id":23,"form":24,"route":25,"label":26,"concentration":27,"markets":31,"refs":32},"tab-10","tablet","oral","10 mg tablet",{"amount":28,"unit":29,"perUnit":24,"scored":30},10,"mg",false,[16],[33],{"source":34,"section":35},"fda-jardiance","3",{"id":37,"form":24,"route":25,"label":38,"concentration":39,"markets":41,"refs":42},"tab-25","25 mg tablet",{"amount":40,"unit":29,"perUnit":24,"scored":30},25,[16],[43],{"source":34,"section":35},[45,72],{"id":46,"disease":47,"label":48,"population":51,"type":54,"unit":29,"dose":55,"refs":56,"limits":59,"notes":63},"t2dm","type-2-diabetes",{"fa":49,"en":50},"دیابت نوع ۲ — ۱۰ سال به بالا: ۱۰ mg صبح","Type 2 diabetes — ≥10 y: 10 mg in the morning",{"minAge":52},{"value":28,"unit":53},"year","fixed",{"perDose":28,"dosesPerDay":5},[57],{"source":34,"section":58},"2.2, Table 1",{"maxPerDay":40,"refs":60},[61],{"source":34,"section":62},"2.2",[64],{"text":65,"refs":68},{"fa":66,"en":67},"برای کنترل بیشتر در صورت تحمل ۲۵ mg. برای کنترل قند با eGFR کمتر از ۳۰ توصیه نمی‌شود. کم‌آبی پیش از شروع اصلاح شود.","If tolerated may increase to 25 mg for more control. Not recommended for glycaemic control with eGFR \u003C30. Correct volume depletion first.",[69,70],{"source":34,"section":62},{"source":34,"section":71},"2",{"id":73,"disease":74,"label":75,"population":78,"type":54,"unit":29,"dose":81,"refs":82},"hf","heart-failure",{"fa":76,"en":77},"نارسایی قلبی \u002F بیماری مزمن کلیه — بزرگسال: ۱۰ mg","Heart failure \u002F CKD — adults: 10 mg",{"minAge":79},{"value":80,"unit":53},18,{"perDose":28,"dosesPerDay":5},[83],{"source":34,"section":58},[85,94],{"id":86,"severity":87,"text":88,"refs":91},"ci","block",{"fa":89,"en":90},"حساسیت به امپاگلیفلوزین (از جمله آنژیوادم).","Hypersensitivity to empagliflozin (including angioedema).",[92],{"source":34,"section":93},"4",{"id":95,"severity":87,"rule":96,"text":98,"refs":101},"under-10",{"maxAge":97},{"value":28,"unit":53},{"fa":99,"en":100},"زیر ۱۰ سال ثابت نشده.","Not established under 10 years.",[102],{"source":34,"section":103},"8.4",[],[],[],[],{"status":109,"reviewer":110,"date":110},"unverified",null,[112,117],{"regimen":46,"formulation":23,"input":113,"expect":116},{"ageYears":114,"weightKg":115},12,50,{"perDose":28},{"regimen":73,"formulation":23,"input":118,"expect":121},{"ageYears":119,"weightKg":120},65,80,{"perDose":28},1792078534761]